Catalyst Wire Dossier Catalyst Wire Dossier

Rebif New Formulation

Interferon beta-1a · Merck KGaA (EMD Serono)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rebif New Formulation, covering 2014-02-03 to 2014-02-03. Get the full timeline:

Most recent: Clinical Trial Update: An Observational Study to Evaluate Quality of Life (QoL) and Influence of Cognitive Status on QoL in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS) During 2 Years Treatment With Rebif New Formulation (RNF)

See pricing